United States (National)
Not enough data
Troutman Pepper's coverage predominantly focuses on legal and regulatory developments, with a particular emphasis on government announcements and legal policy regulations. The content covered includes various topics such as consumer financial services, cannabis industry, taxation, employment laws, and banking.
Given their focus on legal and compliance issues within these industries, they are likely to be most responsive to pitches offering expert commentary or analysis of recent legislative changes or regulatory updates in the mentioned sectors. Additionally, Troutman Pepper may also be interested in news related to notable settlements between companies and regulatory bodies.
It's important for PR professionals to tailor their pitches specifically towards this legal/regulatory lens when reaching out to Troutman Pepper.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Stefanie Jackman, Jason Cover, Glen Trudel, Chris Willis, Carlin Mccrory, Keith Barnett, Troutman Pepper, Mark Furletti, Joshua Mcbeain
On December 18, the Consumer Financial Protection Bureau (CFPB or Bureau) issued a circular to “other law enforcement agencies,” urging them to take...
By: Troutman Pepper, Stefanie Jackman, Lori Sommerfield, Chris Willis
This week, the Consumer Financial Protection Bureau (CFPB or Bureau) released its semiannual regulatory agenda, outlining its planned rulemaking...
By: Troutman Pepper
In the 12th and final episode of our 12 Days of Regulatory Insights podcast series, Cole White, a member of Troutman Pepper's Regulatory...
By: Chad Fuller, Christopher Capurso, Brooke Conkle, Virginia Bell Flynn, Troutman Pepper
On December 18, the U.S. Court of Appeals for the Eleventh Circuit held oral arguments in Insurance Marketing Coalition Limited (IMC) v. Federal...
By: Christopher Carlson, Troutman Pepper, Stefanie Jackman, Brooke Conkle, Christopher Capurso
In a significant enforcement action, the Federal Trade Commission (FTC) and the Illinois Attorney General have reached a $20 million settlement with...
By: Ethan Ostroff, Thailer Buari, Alan Wingfield, Addison Morgan, Trey Smith, Elizabeth Briones, John Komisin, Troutman Pepper
To keep you informed of recent activities, below are several of the most significant federal and state events that have influenced the Consumer...
By: Bryan Haynes, Agustin Rodriguez
Throughout 2024, the U.S. Food and Drug Administration (FDA) endeavored to curb sales of unauthorized electronic nicotine delivery systems (ENDS) in the U.S. In light of persistent demand for flavored ENDS — nearly all of which are unauthorized — there is little evidence that these enforcement efforts have reduced illicit sales. Indeed, some observers estimate that flavored ENDS account for more than 80% of all ENDS sales. With a new administration on the horizon, our team highlights two opportunities for FDA to step up its enforcement efforts: (1) focusing enforcement on imports and (2) authorizing premarket tobacco product applications (PMTAs) for flavored products.
By: Troutman Pepper
Two former Greenberg Traurig shareholders are also joining the new office which will target corporate and finance work
Samantha R. Weber is an associate at Troutman Pepper, based in the firm’s Philadelphia office. She received her J.D. from Temple University Beasley School of Law, cum laude, where she served as staff editor for the Temple Law Review.
Mike is a partner with Troutman Pepper, based in Philadelphia, where he concentrates his practice in antitrust and competition law, class action litigation, and white collar defense. He has defended clients in a number of Sherman Act conspiracy cases and has substantial experience counseling companies on antitrust compliance, as well as competition law issues present in supplier, distributor, and licensing agreements. He has also litigated against, and represented clients before government enforcers, including the Department of Justice Antitrust Division and state attorneys general, and has worked with clients to structure and complete internal investigations. Mike has significant experience in the pharmaceutical and health care industries, and has also represented clients across many other sectors including agriculture, transportation, and manufacturing. Mike is a member of the Antitrust Law Committee of the American Bar Association, and has regularly presented at CLEs regarding pleading and summary judgment standards in antitrust conspiracy cases.
(833) 317-6278 